Osmol Therapeutics is developing OSM-0205, our lead investigational candidate, to address the urgent need of patients faced with the challenges of chemotherapy-induced peripheral neuropathy (CIPN) and chemotherapy-induced cognitive impairment (CICI) - challenging and debilitating conditions impactin...
Use this information to figure out if this company is an ideal customer for you.
203.606.5600
33 Whitney Avenue
New Haven, 06510
11 - 50 Employees
$1M - $5M
linkedin.com/company/osmol-therapeutics-inc.
Osmol Therapeutics's CEO is Barbara Ehrlich
Osmol Therapeutics's HQ is located at 33 Whitney Avenue, New Haven
Osmol Therapeutics's phone number is 203.606.5600
Osmol Therapeutics's official website is osmoltherapeutics.com
Osmol Therapeutics's revenue is $1M - $5M
Osmol Therapeutics has 11 - 50 employees
Osmol Therapeutics is in the industry of: Pharmaceuticals
